Single dose oral diclofenac for acute postoperative pain in adults
- PMID: 26151766
- PMCID: PMC6485701
- DOI: 10.1002/14651858.CD004768.pub3
Single dose oral diclofenac for acute postoperative pain in adults
Abstract
Background: Diclofenac is a nonsteroidal anti-inflammatory drug, available as a potassium salt (immediate release) or sodium salt (enteric coated to suppress dissolution in the stomach). This review updates an earlier review published in the Cochrane Database of Systematic Reviews (Issue 2, 2009) entitled 'Single dose oral diclofenac for acute postoperative pain in adults'.
Objectives: To assess the analgesic efficacy and adverse effects of a single oral dose of diclofenac for moderate to severe postoperative pain, using methods that permit comparison with other analgesics evaluated in standardised trials using almost identical methods and outcomes.
Search methods: We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, the Oxford Pain Relief Database, two clinical trial registries, and the reference lists of articles. The date of the most recent search was 9 March 2015.
Selection criteria: Randomised, double-blind, placebo-controlled clinical trials of single dose, oral diclofenac (sodium or potassium) for acute postoperative pain in adults.
Data collection and analysis: Two review authors independently considered studies for inclusion in the review, assessed risk of bias, and extracted data. We used the area under the pain relief versus time curve to derive the proportion of participants with at least 50% pain relief over six hours prescribed either diclofenac or placebo. We calculated the risk ratio (RR) and number needed to treat to benefit (NNT). We used information on the use of rescue medication to calculate the proportion of participants requiring rescue medication and the weighted mean of the median time to use. We also collected information on adverse effects.
Main results: This update included three new studies, providing a 26% increase in participants in comparisons between diclofenac and placebo. We included 18 studies involving 3714 participants, 1902 treated with diclofenac and 1007 with placebo. This update has also changed the focus of the review, examining the effects of formulation in more detail than previously. This is a result of increased understanding of the importance of speed of onset in determining analgesic efficacy in acute pain.The largest body of information, for diclofenac potassium 50 mg, in seven studies, produced an NNT for at least 50% of maximum pain relief compared with placebo of 2.1 (95% confidence interval (CI) 1.9 to 2.5) (high quality evidence). There was a graded improvement in efficacy as doses rose from 25 mg to 100 mg, both for participants achieving at least 50% maximum pain relief, and for remedication within 6 to 8 hours. Fast-acting formulations (dispersible products, solutions, and softgel formulations) had a similar efficacy for a 50 mg dose, with an NNT of 2.4 (2.0 to 3.0). Diclofenac sodium in a small number of studies produced a lesser effect, with an NNT of 6.6 (4.1 to 17) for the 50 mg dose.Adverse event rates were low in these single dose studies, with no difference between diclofenac and placebo (moderate quality evidence).
Authors' conclusions: Diclofenac potassium provides good pain relief at 25 mg, 50 mg, and 100 mg doses. Diclofenac sodium has limited efficacy and should probably not be used in acute pain.
Conflict of interest statement
SD has no conflicts relating to this review or any similar product.
PW has no conflicts relating to this review or any similar product.
RAM has no conflicts relating to this review or any similar product.
For transparency, SD, PW, and RAM have received research support from charities, government, and industry sources at various times, but none relate to this review. SD, PW, and RAM are funded by the NIHR for work on a series of reviews informing the unmet need of chronic pain and providing the evidence for treatments of pain.
Figures










Update of
-
Single dose oral diclofenac for acute postoperative pain in adults.Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004768. doi: 10.1002/14651858.CD004768.pub2. Cochrane Database Syst Rev. 2009. Update in: Cochrane Database Syst Rev. 2015 Jul 07;(7):CD004768. doi: 10.1002/14651858.CD004768.pub3. PMID: 19370609 Free PMC article. Updated.
References
References to studies included in this review
Ahlstrom 1993 {published data only}
-
- Ahlstrom U, Bakshi R, Nilsson P, Wahlander L. The analgesic efficacy of diclofenac dispersible and ibuprofen in postoperative pain after dental extraction. European Journal of Clinical Pharmacology 1993;44(6):587‐8. - PubMed
Bakshi 1992 {published data only}
-
- Bakshi R, Jacobs LD, Lehnert S, Picha B, Reuther J. A double‐blind, placebo controlled trial comparing the analgesic efficacy of two formulations of diclofenac in postoperative dental pain. Current Therapeutic Research 1992;52(3):435‐42.
Bakshi 1994 {published data only}
-
- Bakshi R, Frenkel G, Dietlein G, Meurer Witt B, Schneider B, Sinterhauf U. A placebo‐controlled comparative evaluation of diclofenac dispersible versus ibuprofen in postoperative pain after third molar surgery. Journal of Clinical Pharmacology 1994;34(3):225‐30. - PubMed
Chang 2002 {published data only}
-
- Chang DJ, Desjardins PJ, Chen E, Polis AB, McAvoy M, Mockoviak SH, et al. Comparison of the analgesic efficacy of rofecoxib and enteric‐coated diclofenac sodium in the treatment of postoperative dental pain: a randomized, placebo‐controlled clinical trial. Clinical Therapeutics 2002;24(4):490‐503. - PubMed
Cooper 1996 {published data only}
-
- Cooper SA, Cowan A, Tallarida RJ, Hargreaves K, Roszkowski M, Jamali F, et al. The analgesic interaction of misoprostol with nonsteroidal anti‐inflammatory drugs. American Journal of Therapeutics 1996;3(4):261‐7. - PubMed
Desjardins 2004 {published data only}
-
- Desjardins PJ, Black PM, Daniels S, Bird SR, Fitzgerald BJ, Petruschke RA, et al. A randomized controlled study comparing rofecoxib, diclofenac sodium, and placebo in post‐bunionectomy pain. Current Medical Research and Opinion 2004;20(10):1523‐37. - PubMed
Herbertson 1995 {published data only}
-
- Herbertson RM, Storey N. The comparative efficacy of diclofenac potassium, aspirin and placebo in the treatment of patients with pain following gynecologic surgery. Today's Therapeutic Trends 1995;12(Suppl 1):33‐45.
Hersh 2004 {published data only}
Hofele 2006 {published data only}
-
- Hofele CM, Gyenes V, Daems LN, Stypula‐Ciuba B, Wagener H, et al. Efficacy and tolerability of diclofenac potassium sachets in acute postoperative dental pain: a placebo‐controlled, randomised, comparative study vs. diclofenac potassium tablets. International Journal of Clinical Practice 2006;60(3):300‐7. [DOI: 10.1111/j.1368-5031.2006.00828.x] - DOI - PubMed
Kubitzek 2003 {published data only}
-
- Kubitzek F, Ziegler G, Gold MS, Liu JM, Ionescu E. Analgesic efficacy of low‐dose diclofenac versus paracetamol and placebo in postoperative dental pain. Journal of Orofacial Pain 2003;17(3):237‐44. - PubMed
Manvelian 2012a {published data only}
Mehlisch 1995 {published data only}
-
- Mehlisch DR, Brown P. Single‐dose therapy with diclofenac potassium, aspirin or placebo following dental impaction surgery. Today's Therapeutic Trends 1995;12(Suppl 1):15‐31.
Nelson 1994 {published data only}
-
- Nelson S, Brahim J. An evaluation of the analgesic efficacy of diclofenac potassium, aspirin, and placebo in postoperative dental pain. Today's Therapeutic Trends 1994;12:3‐14.
Olson 1997 {published data only}
-
- Olson NZ, Sunshine A, Zighelboim I, DeCastro A. Onset and duration of analgesia of diclofenac potassium in the treatment of postepisiotomy pain. American Journal of Therapeutics 1997;4:239‐46. - PubMed
Riff 2009 {published data only}
-
- Riff DS, Duckor S, Gottlieb I, Diamond E, Soulier S, Raymond G, et al. Diclofenac potassium liquid‐filled soft gelatin capsules in the management of patients with postbunionectomy pain: a Phase III, multicenter, randomized, double‐blind, placebo‐controlled study conducted over 5 days. Clinical Therapeutics 2009;31(10):2072‐85. [DOI: 10.1016/j.clinthera.2009.09.011] - DOI - PubMed
Torres 2004 {published data only}
-
- Torres LM, Cabrera J, MartÍnez J, Calderón E, Fernández S, Chaves J. The specific cox‐2 inhibitor valdecoxib provides effective analgesia after inguinal hernia surgery. Revista Espanola Anestesiologia y Reanimacion 2004;51(10):576‐82. - PubMed
Zuniga 2004 {published data only}
Zuniga 2010 {published data only}
-
- Zuniga JR, Malmström H, Noveck RJ, Campbell JH, Christensen S, Glickman RS, et al. Controlled phase III clinical trial of diclofenac potassium liquid‐filled soft gelatin capsule for treatment of postoperative dental pain. Journal of Oral and Maxillofacial Surgery 2010;68(11):2735‐42. [DOI: 10.1016/j.joms.2010.05.075.] - DOI - PubMed
References to studies excluded from this review
Daniels 2012 {published data only}
-
- Daniels SE, Riff D, Diamond E, Clark F, Boesing SE. An assessment of the efficacy and safety of diclofenac potassium liquid‐filled capsules inpatients with various levels of baseline pain intensity. Current Medical Research & Opinion 2012;28(6):953‐61. [DOI: 10.1185/03007995.2012.694363] - DOI - PubMed
References to ongoing studies
NCT01462435 {published data only}
-
- NCT01462435. Study of diclofenac capsules to treat pain following bunionectomy. www.clinicaltrials.gov/ct2/results?term=NCT01462435+&Search=Search (accessed 9 March 2015). [Clinicaltrials.gov: NCT01462435 ]
Additional references
Chen 2015
Clarke 2012
Collins 1997
Collins 1998
Collins 2001
Cook 1995
Cooper 1991
-
- Cooper SA. Single‐dose analgesic studies: the upside and downside of assay sensitivity. In: Max MB, Portenoy RK, Laska EM editor(s). The design of analgesic clinical trials. Advances in Pain Research and Therapy. Vol. 18, New York: Raven Press, 1991:117‐24.
Dechartres 2013
Derry 2009b
Derry 2010
Derry 2013a
Derry 2013b
Derry 2013c
Fineschi 1997
-
- Fineschi G, Tamburrelli FC, Francucci BM, Pisati R. Oral diclofenac dispersible provides a faster onset of analgesia than intramuscular ketorolac in the treatment of postoperative pain. Clinical Drug Investigation 1997;13:1‐7.
FitzGerald 2001
Forrest 2002
Grahame‐Smith 2002
-
- Grahame‐Smith DG, Aronson JK. Oxford Textbook of Clinical Pharmacology and Drug Therapy. 3rd Edition. Oxford: Oxford University Press, 2002. [ISBN: 13: 978‐0‐19‐263234‐0]
Hawkey 1999
Hernández‐Díaz 2001
-
- Hernández‐Díaz S, García‐Rodríguez LA. Epidemiologic assessment of the safety of conventional nonsteroidal anti‐inflammatory drugs. American Journal of Medicine 2001;110(Suppl 3A):20S‐7S. [DOI: ] - PubMed
Higgins 2011
-
- Higgins JPT, Altman DG, Sterne JAC (editors). Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Jadad 1996a
Jadad 1996b
L'Abbé 1987
Manvelian 2012b
Martindale 2015
-
- Diclofenac. Martindale: The Complete Drug Reference (available at: medicinescomplete.com/mc/martindale/current/ms‐13409‐w.htm?q=diclofenac&...) (accessed 9 March 2015). The Pharmaceutical Press, 2015.
McQuay 2005
McQuay 2012
Moore 1997a
Moore 1997b
Moore 1998
Moore 2003
-
- Moore RA, Edwards J, Barden J, McQuay HJ. Bandolier's Little Book of Pain. Oxford: Oxford University Press, 2003. [ISBN: 0‐19‐263247‐7]
Moore 2005
Moore 2006
-
- Moore A, McQuay H. Bandolier's Little Book of Making Sense of the Medical Evidence. Oxford: Oxford University Press, 2006. [ISBN: 0‐19‐856604‐2]
Moore 2008
-
- Moore RA, Barden J, Derry S, McQuay HJ. Managing potential publication bias. In: McQuay HJ, Kalso E, Moore RA editor(s). Systematic Reviews in Pain Research: Methodology Refined. Seattle: IASP Press, 2008:15‐24. [ISBN: 978‐0‐931092‐69‐5]
Moore 2011a
Moore 2011b
-
- Moore RA, Straube S, Paine J, Derry S, McQuay HJ. Minimum efficacy criteria for comparisons between treatments using individual patient meta‐analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen/paracetamol combinations after third molar extraction. Pain 2011;152(5):982‐9. [DOI: 10.1016/j.pain.2010.11.030] - DOI - PubMed
Moore 2013
Moore 2014
Moore 2015a
Moore 2015b
Morris 1995
-
- Morris JA, Gardner MJ. Calculating confidence intervals for relative risk, odds ratio and standardised ratios and rates. In: Gardner MJ, Altman DG editor(s). Statistics With Confidence ‐ Confidence Intervals and Statistical Guidelines. London: British Medical Journal, 1995:50‐63. [ISBN: 0‐7279‐0222‐9] - PMC - PubMed
Nüesch 2010
PCA 2014
-
- Prescribing and Primary Care team, Health and Social Care Information Centre. Prescription Cost Analysis, England 2013. hscic.gov.uk/catalogue/PUB13887/pres‐cost‐anal‐eng‐2013‐rep.pdf (accessed 9 March 2015). [ISBN: 978‐1‐78386‐089‐0]
Rapoport 1999
-
- Rapoport RJ. The safety of NSAIDs and related drugs for the management of acute pain: maximizing benefits and minimizing risks. Cancer Control 1999;6(2 Suppl 1):18‐21. [PUBMED: 12118235] - PubMed
RevMan 2014 [Computer program]
-
- Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Scallion 2009
Toms 2008
Tramèr 1997
Willis 1979
-
- Willis JV, Kendall MJ, Flinn RM, Thornhill DP, Welling PG. The pharmacokinetics of diclofenac sodium following intravenous and oral administration. European Journal of Clinical Pharmacology 1979;16(6):405‐10. [PUBMED: 527637] - PubMed
References to other published versions of this review
Barden 2004
Collins 1999
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources